Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis.

Published in: Lung (2020)

Benralizumab, dupilumab, mepolizumab, and reslizumab are all associated with decreased asthma exacerbations in patients with eosinophilic asthma, with no significant inter-drug differences.

Keyphrases

chronic obstructive pulmonary disease
lung function
cystic fibrosis
allergic rhinitis
atopic dermatitis
bone marrow